Are there any specific monitoring parameters that dermatologists should follow during treatment with lebrikizumab?

Featuring Mona Shahriari, MD | Associate Clinical Professor of Dermatology, Yale University; Associate Director of Clinical Trials, Central CT Dermatology Research, Cromwell, CT | Published November 06, 2024